Compare LOVE & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LOVE | SGMO |
|---|---|---|
| Founded | 1998 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 177.7M | 155.1M |
| IPO Year | 2018 | 2000 |
| Metric | LOVE | SGMO |
|---|---|---|
| Price | $12.54 | $0.46 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 7 |
| Target Price | ★ $30.00 | $4.71 |
| AVG Volume (30 Days) | 612.1K | ★ 9.2M |
| Earning Date | 12-11-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5.90 | N/A |
| EPS | ★ 0.46 | N/A |
| Revenue | ★ $690,559,000.00 | $32,875,000.00 |
| Revenue This Year | $6.93 | $1.37 |
| Revenue Next Year | $7.52 | N/A |
| P/E Ratio | $27.84 | ★ N/A |
| Revenue Growth | ★ 0.13 | N/A |
| 52 Week Low | $11.26 | $0.38 |
| 52 Week High | $38.67 | $2.84 |
| Indicator | LOVE | SGMO |
|---|---|---|
| Relative Strength Index (RSI) | 38.92 | 44.69 |
| Support Level | $13.76 | $0.49 |
| Resistance Level | $14.04 | $0.51 |
| Average True Range (ATR) | 0.68 | 0.05 |
| MACD | 0.07 | 0.01 |
| Stochastic Oscillator | 38.00 | 37.85 |
The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.